Exubrion Therapeutics Revenue, Growth & Competitor Profile

DBA CONVETRA INC

Company Profile & Annual Report for Exubrion Therapeutics

Access the complete profile.

Exubrion Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	5203 Bristol Ind Way Buford, GA 30518

Note: Revenues for privately held companies are statistical evaluations.


Exubrion Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Exubrion Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Exubrion Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Exubrion Therapeutics Annual Revenue and Growth Rate

Exubrion Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Exubrion Therapeutics's revenues are gauged from an analysis of company filings.

Exubrion Therapeutics's Income Statement (based on Industry Averages)

Exubrion Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Exubrion Therapeutics is developing and marketing. Exubrion Therapeutics doesn't have any recent trademark applications, indicating Exubrion Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
EXUBRION THERAPEUTICS Veterinary preparations, namely, veterinary radio-therapeutic preparations	05/07/2019
SYNOVETIN OA Veterinary preparations, namely, veterinary radio-therapeutic preparations inserted into an animal for the reduction of inflammation and pain	02/04/2019
CONVETRA Veterinary preparations, namely, veterinary radio-therapeutic preparations	02/04/2019

See all trademarks and details in the Full Report.

Market Share of Exubrion Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Exubrion Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Exubrion Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NOX HEALTH GROUP	Gainesville, GA	100
PROJECT CHIMPS	Blue Ridge, GA	34
KISMET RUBBER PRODUCTS	Blue Ridge, GA	19
ORIANNE SOCIETY	Tiger, GA	13
EXUBRION THERAPEUTICS	Buford, GA	10
SOUTHEASTERN BIOCHEMICALS	Sautee Nacoochee, GA	3

Future Competition: Exubrion Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Exubrion Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)